Home › Funds › Grand Central Investment Group › GILD

Grand Central Investment Group position in GILD

GILEAD SCIENCES INC · Health Care

Grand Central Investment Group reported holding 15,027 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 1.73% of its reported portfolio and ranking #23 among its reported holdings. Grand Central Investment Group has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)15.03K sh
Reported value held$2.24M
Portfolio Weight1.73%
First reportedQ4 2025
Last changeReduce
Updated2026-11-03

Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR

How Grand Central Investment Group's GILD position evolved

Grand Central Investment Group first disclosed a stake in GILD in Q4 2025 at 15,433 shares (US$1.9M). The position peaked in Q3 2026 at 15,027 shares, worth US$2.2M. Across 4 filings, Grand Central Investment Group increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 15,027 shares valued at US$2.2M — a reduction of -234 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 15.43K $1.89M New
Q1 2026 15.43K $2.15M Hold
Q2 2026 15.26K $1.93M Reduce
Q3 2026 15.03K $2.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Grand Central Investment Group held GILD?

Grand Central Investment Group has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Grand Central Investment Group's current position in GILD?

As of Q3 2026, Grand Central Investment Group holds 15.03K shares of GILD (GILEAD SCIENCES INC), valued at $2.24M, representing 1.73% of its reported portfolio and ranking #23.

Has Grand Central Investment Group been buying or selling GILD?

In the latest 13F filing (Q3 2026), Grand Central Investment Group reduced its position in GILD. The position peaked in Q3 2026 at 15.03K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.